These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 17018627
1. The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth. Akakura N, Hoogland C, Takada YK, Saegusa J, Ye X, Liu FT, Cheung AT, Takada Y. Cancer Res; 2006 Oct 01; 66(19):9691-7. PubMed ID: 17018627 [Abstract] [Full Text] [Related]
2. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells. He GA, Luo JX, Zhang TY, Hu ZS, Wang FY. Biochem Biophys Res Commun; 2004 May 28; 318(2):354-60. PubMed ID: 15120609 [Abstract] [Full Text] [Related]
8. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2. Oh HK, Ha JM, O E, Lee BH, Lee SK, Shim BS, Hong YK, Joe YA. Cancer Res; 2007 May 15; 67(10):4851-9. PubMed ID: 17510415 [Abstract] [Full Text] [Related]
9. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY. Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341 [Abstract] [Full Text] [Related]
10. Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells. Bandyopadhyay A, Zhu Y, Malik SN, Kreisberg J, Brattain MG, Sprague EA, Luo J, López-Casillas F, Sun LZ. Oncogene; 2002 May 16; 21(22):3541-51. PubMed ID: 12032856 [Abstract] [Full Text] [Related]
11. The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo. Vandercappellen J, Liekens S, Bronckaers A, Noppen S, Ronsse I, Dillen C, Belleri M, Mitola S, Proost P, Presta M, Struyf S, Van Damme J. Mol Cancer Res; 2010 Mar 16; 8(3):322-34. PubMed ID: 20215425 [Abstract] [Full Text] [Related]
13. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Yee AJ, Akens M, Yang BL, Finkelstein J, Zheng PS, Deng Z, Yang B. Breast Cancer Res; 2007 Mar 16; 9(4):R47. PubMed ID: 17662123 [Abstract] [Full Text] [Related]
14. Identification of an active site on the laminin alpha4 chain globular domain that binds to alphavbeta3 integrin and promotes angiogenesis. Lian J, Dai X, Li X, He F. Biochem Biophys Res Commun; 2006 Aug 18; 347(1):248-53. PubMed ID: 16824487 [Abstract] [Full Text] [Related]
15. The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formation. Li H, Shi X, Liu J, Hu C, Zhang X, Liu H, Jin J, Opolon P, Vannier JP, Perricaudet M, Janin A, Soria C, Lu H. Cancer Gene Ther; 2010 Oct 18; 17(10):700-7. PubMed ID: 20559333 [Abstract] [Full Text] [Related]
18. Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins. Magnon C, Galaup A, Mullan B, Rouffiac V, Bouquet C, Bidart JM, Griscelli F, Opolon P, Perricaudet M. Cancer Res; 2005 May 15; 65(10):4353-61. PubMed ID: 15899827 [Abstract] [Full Text] [Related]
19. Fibrinogen induces cytokine and collagen production in pancreatic stellate cells. Masamune A, Kikuta K, Watanabe T, Satoh K, Hirota M, Hamada S, Shimosegawa T. Gut; 2009 Apr 15; 58(4):550-9. PubMed ID: 19052021 [Abstract] [Full Text] [Related]
20. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases. Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH. Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973 [Abstract] [Full Text] [Related] Page: [Next] [New Search]